Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Globe Newswire News Releases

May 14, 2024 08:07 ET
DRFortress Expands Cloud Connectivity Capabilities for Hawaii Businesses with Megaport Cloud Connect
DRFortress, the largest carrier-neutral data center and cloud marketplace operating in Hawaii, announces that it has launched a new public cloud on-ramp solution with Megaport, a global pioneer in Network as a Service (NaaS) solutions, to offer...
May 14, 2024 08:06 ET
Sysco Celebrates Arrival of Heavy-Duty Electric Vehicles in Its Headquarters City of Houston, TX, Growth of Electric Fleet Globally
Sysco is hosting a news conference to celebrate the arrival of new heavy duty electric vehicles to the company’s hometown Houston distribution facility, the first for Sysco in Texas. The company will also announce its progress in deploying EVs...
May 14, 2024 08:05 ET
Bitcoin Depot Reports First Quarter 2024 Financial Results
Bitcoin Depot Inc. (“Bitcoin Depot” or the “Company”), a U.S.-based Bitcoin ATM operator and leading fintech company, today reported financial results for the first quarter ended March 31, 2024. Bitcoin Depot will host a conference call and webcast...
May 14, 2024 08:05 ET
OpsMx Receives Coveted Industry Recognition
OpsMx, the secure software delivery company, today announced it has garnered recognition from three key industry award programs. OpsMx received a Bronze Stevie Award for OpsMx Delivery Shield in the DevOps Solution category. The company was also...
May 14, 2024 08:05 ET
Palisade Bio Reports First Quarter 2024 Financial Results and Provides Business Update
Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio” or the “Company”), a biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today...
May 14, 2024 08:00 ET
Jasper Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Developments
Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address mast cell driven diseases such as chronic spontaneous...
May 14, 2024 08:00 ET
Franklin Electric Appoints Joe Ruzynski as CEO; Gregg Sengstack Remains Executive Chairperson
Franklin Electric Co., Inc. (NASDAQ: FELE), a global leader in water and energy systems, announced today that its Board of Directors has appointed Joe Ruzynski as Chief Executive Officer and a member of the Board, effective July 1, 2024. Gregg...
May 14, 2024 08:00 ET
Ocugen Provides Business Update with First Quarter 2024 Financial Results
Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, and vaccines, today reported first quarter 2024 financial results along with a...
May 14, 2024 08:00 ET
Middlefield Banc Corp. Announces 2024 Second-Quarter Cash Dividend Payment
Middlefield Banc Corp. (NASDAQ: MBCN) today announced that its Board of Directors declared a quarterly cash dividend of $0.20 per common share. The second-quarter dividend is payable on June 14, 2024, to shareholders of record on May 31, 2024....
May 14, 2024 08:00 ET
89bio Initiates Phase 3 ENLIGHTEN-Cirrhosis Trial of Pegozafermin in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Patients with Compensated Cirrhosis
89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced the initiation of...
May 14, 2024 08:00 ET
Acrivon Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biopharmaceutical company developing precision oncology medicines that it matches to patients whose tumors are predicted to be sensitive to each...
May 14, 2024 08:00 ET
Apellis Pharmaceuticals Refinances Existing Debt with Up to $475 Million Non-Dilutive Credit Facility from Sixth Street
Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), today announced that it has entered into a non-dilutive, senior secured credit facility with Sixth Street, a leading global investment firm, of up to $475 million, with approximately $375 million funded...
May 14, 2024 08:00 ET
aTyr Pharma Announces Second Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis
aTyr Pharma, Inc. (Nasdaq: LIFE) (aTyr or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced that an independent...
May 14, 2024 08:00 ET
Belite Bio to Participate in the Benchmark’s 4th Annual Healthcare House Call Investor Conference
Belite Bio, Inc. (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that the...
May 14, 2024 08:00 ET
BetterLife Obtains Excellent Animal Cardiopulmonary Safety Data for Oral BETR-001
BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development of BETR-001, a non-hallucinogenic derivative of lysergic acid diethylamide (“LSD”), announced it...
May 14, 2024 08:00 ET
BranchOut Food Secures Large Scale Production Facility in Peru Capable of $40M in Production Capacity; Estimated 40-50% Gross Margins
BranchOut Food Inc. (NASDAQ: BOF), a pioneering food technology company and producer of dehydrated fruit and vegetable-based products, today announced that it has signed a long term lease for a 50,000 square foot production facility in Peru. Under...
May 14, 2024 08:00 ET
Candel Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today reported financial results for the first...
May 14, 2024 08:00 ET
Clene to Present at Upcoming May Conferences
Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to...
May 14, 2024 08:00 ET
Compass Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in a...
May 14, 2024 08:00 ET
Coveo Announces New Partnership with Genesys to Empower Contact Center Agents with AI Search, Recommendations, and Generative Answering
Coveo (TSX:CVO), the leading enterprise AI platform that brings AI search and GenAI to every point-of-experience, enabling remarkable personalized digital experiences that drive business outcomes, today announced Coveo for Genesys Cloud is now...